Evidence map›Paper›PMID 25714841›Full record

ArticlePloS one2015

Integrin mediated adhesion of osteoblasts to connective tissue growth factor (CTGF/CCN2) induces cytoskeleton reorganization and cell differentiation.

Honey Hendesi, Mary F Barbe, Fayez F Safadi, M Alexandra Monroy, Steven N Popoff

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Bone matrix proteins: regulators of skeletal remodeling and repair.Journal of bone and mineral metabolism · 2026
    Review
  4. Conditional deletion ofFrontiers in cell and developmental biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Connective Tissue Growth Factor: Regulation, Diseases, and Drug Discovery.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Targeting integrin pathways: mechanisms and advances in therapy.Signal transduction and targeted therapy · 2023
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Honey HendesiDepartment of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America.
Mary F BarbeDepartment of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America.
Fayez F SafadiDepartment of Anatomy and Neurobiology, Northeast Ohio Medical University (NEOMED), Rootstown, Ohio, United States of America.
M Alexandra MonroyDepartment of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America; Department of Surgery, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America.
Steven N PopoffDepartment of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America; Department of Orthopedic Surgery, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America.
Temple University · USNortheast Ohio Medical University · US

Funding

THE ROLE OF CTGF IN OSTEOBLAST DEVELOPMENT AND FUNCTIONR01AR047432 · NIAMS · TEMPLE UNIV OF THE COMMONWEALTH · PI POPOFF, STEVEN N. · 2002 to 2012
$3.1M
NIAMS NIH HHS R01 AR047432NIAMS NIH HHS R01 AR47432
6 · The paper itself

Abstract

Pre-osteoblast adhesion and interaction with extracellular matrix (ECM) proteins through integrin receptors result in activation of signaling pathways regulating osteoblast differentiation. Connective tissue growth factor (CTGF/CCN2) is a matricellular protein secreted into the ECM. Prior studies in various cell types have shown that cell adhesion to CTGF via integrin receptors results in activation of specific signaling pathways that regulate cell functions, such as differentiation and cytoskeletal reorganization. To date, there are no studies that have examined whether CTGF can serve as an adhesive substrate for osteoblasts. In this study, we used the MC3T3-E1 cell line to demonstrate that CTGF serves as an adhesive matrix for osteoblasts. Anti-integrin blocking experiments and co-immunoprecipitation assays demonstrated that the integrin αvβ1 plays a key role in osteoblast adhesion to a CTGF matrix. Immunofluorescence staining of osteoblasts cultured on a CTGF matrix confirmed actin cytoskeletal reorganization, enhanced spreading, formation of focal adhesions, and activation of Rac1. Alkaline phosphatase (ALP) staining and activity assays, as well as Alizarin red staining demonstrated that osteoblast attachment to CTGF matrix enhanced maturation, bone nodule formation and matrix mineralization. To investigate whether the effect of CTGF on osteoblast differentiation involves integrin-mediated activation of specific signaling pathways, we performed Western blot, chromatin immunoprecipitation (ChIP) and qPCR assays. Osteoblasts cultured on a CTGF matrix showed increased total and phosphorylated (activated) forms of focal adhesion kinase (FAK) and extracellular signal-regulated kinase (ERK). Inhibition of ERK blocked osteogenic differentiation in cells cultured on a CTGF matrix. There was an increase in runt-related transcription factor 2 (Runx2) binding to the osteocalcin gene promoter, and in the expression of osteogenic markers regulated by Runx2. Collectively, the results of this study are the first to demonstrate CTGF serves as a suitable matrix protein, enhancing osteoblast adhesion (via αvβ1 integrin) and promoting cell spreading via cytoskeletal reorganization and Rac1 activation. Furthermore, integrin-mediated activation of ERK signaling resulted in increased osteoblast differentiation accompanied by an increase in Runx2 binding to the osteocalcin promoter and in the expression of osteogenic markers.

Indexed as

Cell DifferentiationAnimalsCell AdhesionCell LineConnective Tissue Growth FactorCore Binding Factor Alpha 1 SubunitCytoskeletonExtracellular Signal-Regulated MAP KinasesFocal Adhesion Protein-Tyrosine KinasesIntegrinsMiceOsteoblastsrac GTP-Binding ProteinsReceptors, VitronectinSignal TransductionTranscriptional ActivationConnective Tissue Growth FactorCore Binding Factor Alpha 1 SubunitExtracellular Signal-Regulated MAP KinasesFocal Adhesion Protein-Tyrosine Kinasesintegrin alphavbeta1Integrinsrac GTP-Binding ProteinsReceptors, Vitronectin

Identifiers

PMID25714841
PMCPMC4340870
OpenAlexW2009514730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.